Gyre Therapeutics Inc.(GYRE:US)

Market Cap$644.69M

Key Metrics

Price$6.08

Revenue (TTM)$119.38M

Holders Revenue (TTM)-

Gross Profit (TTM)$112.58M

Earnings (TTM)-$17.41M

EBITDA (TTM)-$7.89M

Op. Margin (TTM)-11.41%

Dividend Yield-

Holders Yield-

Cash on hand$37.5M

Total Assets$162.02M

Net Assets$136.99M

Total Debt$823K

Gyre Therapeutics Inc.(GYRE:US)

Market Cap$644.69M

Price history

Key Metrics

Price$6.08

Revenue (TTM)$119.38M

Holders Revenue (TTM)-

Gross Profit (TTM)$112.58M

Earnings (TTM)-$17.41M

EBITDA (TTM)-$7.89M

Op. Margin (TTM)-11.41%

Dividend Yield-

Holders Yield-

Cash on hand$37.5M

Total Assets$162.02M

Net Assets$136.99M

Total Debt$823K

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2022
Revenue
$29.11M$22.52M$37.2M$30.56M$26.77M$22.06M$27.87M$25.49M$25.23M$27.17M$27.15M$32.04M$29.33M$3.42M$3.43M
Cost of Revenue
$2.21M$1.23M$1.74M$1.63M$1.15M$894K$1.18M$958K$770K$979K$1.25M$1.18M$1.08M$154.45K$164.62K
Gross Profit
$26.9M$21.29M$35.45M$28.94M$25.62M$21.16M$26.7M$24.53M$24.46M$26.19M$25.9M$30.86M$28.25M$3.27M$3.27M
$40.76M$28.09M$35.33M$22.01M$23.45M$18.89M$26.03M$20.3M$21.19M$18.12M$31.09M$18.09M$23.28M$2.35M$2.17M
Research and Development$19.14M$6.74M$4.82M$2.36M$3.43M$3.1M$3.71M$2.78M$3.36M$2.18M$4.57M$3.01M$3.57M$361.76K$284.64K
Selling, General, and Administrative$21.62M$21.36M$30.52M$19.65M$20.02M$15.8M$22.32M$17.52M$17.84M$15.94M$26.52M$15.09M$19.71M$1.99M$1.89M
Other Operating Expenses---------------
Operating Income
-$13.86M-$6.8M$120K$6.93M$2.17M$2.27M$663K$4.23M$3.26M$8.07M-$5.19M$12.76M$4.97M$914.91K$1.1M
-$573K-$2.44M-$1.93M$703K$66K$2.36M$109K-$303K$2.42M$4.41M-$95.42M-$1.58M$629K$103.75K-$7.02K
Non-Operating Interest Income$740K-----$346K$523K-$328K-$283K-$184K-
Non-Operating Interest Expense-------------$1.04K$1.88K
Other Income/Expense-$1.31M-$2.44M-$1.93M$703K$66K$2.36M-$237K-$826K$2.42M$4.08M-$95.42M-$1.86M$629K-$79.22K-$5.14K
Income Before Tax
-$14.43M-$9.24M-$66K$7.63M$2.24M$4.64M$772K$3.93M$6.04M$12.48M-$100.28M$11.19M$5.85M$860.96K$1.09M
Income Tax
-$164K$621K$1.3M$1.69M$662K$901K$203K$1.07M$1.5M$2.55M$699K$3.68M$2.08M$282K$244.36K
Net Income
-$14.27M-$9.86M-$1.37M$5.94M$1.58M$3.73M$569K$2.86M$4.54M$9.94M-$100.98M$7.51M$3.77M$578.96K$844.56K
Minority Interests
$3.67M$1.17M-$357K-$2.33M-$1.13M-$1.04M-$668K-$1.73M-$1.01M-$2.4M-$29K-$3.53M-$1.92M-$1.97M-
Preferred Stock Dividends
---------------
Net Income to Common
-$10.61M-$8.69M-$1.72M$3.61M$442K$2.7M-$99K$1.12M$3.53M$7.53M-$101.01M$3.98M$1.85M-$1.39M$844.56K
Shares Outstanding (Basic)
100.64M91.32M91.16M90.85M89.12M86.42M85.95M85.64M85.5M83.27M-76.58M76.58M76.58M76.58M
Shares Outstanding (Diluted)
100.64M91.34M91.16M103.97M102.7M101.97M85.95M102.64M104.33M102.59M-76.58M76.58M76.58M76.58M
EPS (Basic)
-$0.12-$0.10-$0.02$0.04$0$0.03$0$0.01$0.04$0.09-$0.052$0.024$0.029$0.08
EPS (Diluted)
-$0.12-$0.10-$0.02$0.03$0$0$0$0.01$0.01$0.03-$0.052$0.024$0.029$0.08
EBIT
-$13.86M-$6.8M$120K$6.93M$2.17M$2.27M$663K$4.23M$3.26M$8.07M-$5.19M$12.76M$4.97M$914.91K$1.09M
EBITDA
-$12.01M-$3.67M$554K$7.23M$2.6M$553K$938K$4.94M$665K$4.21M$90.3M$13.49M$5.29M$954.18K$1.16M